Sector Chart Kintor Pharmaceutical Limited OTC Markets
Stocks
KNTPF
KYG5273B1077
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3420 USD | +22.10% |
|
+22.10% | +58.33% |
| 06-10 | Kintor Pharma Posts Positive Interim Safety Data for Whitening Agent KT-939 | MT |
| 05-28 | Kintor pharmaceutical says CEO via wholly owned co increases shareholding by 2.51 million shares | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 54.44B | |||||
| 45.8B | |||||
| 22.98B | - | ||||
| 20.76B | - | ||||
| 16.25B |
Select your edition
All financial news and data tailored to specific country editions
